xCures
PrivateLast Round
Series B
Jun 24, 2026
Est. Valuation
$127M
Total Funding Raised
$61.09M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
xCures operates in Healthcare & Life Sciences and is based in Oakland, California. Its latest recorded funding round was a Series B round in June 2026.
xCures is a healthcare technology company that operates an AI-assisted platform to aggregate, normalize, and structure fragmented medical records into a searchable database for clinical insights.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
xCures Comparables
Compare xCures with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensemble Health Partners | 83% | |
| Verana Health | 83% | |
| ConcertAI | 81% |
For institutional investors. Book with your work email.
xCures Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 24, 2026 | ||||
| Series A | Jun 23, 2021 | ||||
| Convertible Debt | Aug 19, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
xCures Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metaplanet Holdings | Series A |
| Vanedge Capital | Series A |
| Innovius Capital | Series B |
| iGrow Venture Partners | Series B |
| Boehringer Ingelheim Venture Fund | Series A |
| Harmonix Fund | Series A |
| Spring Mountain Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 22% QoQ, from 58 to 71 employees.
- Jul 27, 2026
Grew 37% QoQ, from 51 to 70 employees.
For institutional investors. Book with your work email.
xCures Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about xCures's valuation, stock price, and market status.
Is xCures a public or private company?
xCures is a private company.
What is the current stock price of xCures?
xCures is a private company, so its shares have no public market price. Caplight tracks xCures's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is xCures worth (valuation)?
xCures's valuation is estimated at $127.0M based on funding round data.
Can I buy xCures stock?
xCures shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was xCures's last funding round?
xCures's most recent funding round was Series B on June 24, 2026.
Who are the main investors in xCures?
Key investors in xCures include Innovius Capital, Boehringer Ingelheim Venture Fund.
Will xCures IPO soon?
No public IPO plans have been announced for xCures.
How can I track xCures secondary market activity?
Caplight tracks bids, offers, and trades in xCures's shares on secondary markets.